NovoLog Mix 70/30
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0169-2201 -
Package NDC
0169-2201-25 -
Application number
BLA021172 -
SPL ID
f999a4d9-129e-4cb2-88cb-2a855468882f -
SPL set ID
1861fcee-7673-4afe-a206-08fa05c0add2 -
UNII
D933668QVX -
RxCUI
351297 -
RxCUI
847191 -
RxCUI
977840 -
RxCUI
977842
What the source publishes
- Labeler
- Novo Nordisk Pharmaceutical Industries, LP
- Active ingredients
- insulin aspart
- Form
- INJECTION, SUSPENSION
- Routes
- SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "NovoLog Mix 70/30",
"splId": "f999a4d9-129e-4cb2-88cb-2a855468882f",
"labels": [
{
"setId": "1861fcee-7673-4afe-a206-08fa05c0add2",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1861fcee-7673-4afe-a206-08fa05c0add2",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1861fcee-7673-4afe-a206-08fa05c0add2"
}
],
"routes": [
"SUBCUTANEOUS"
],
"labeler": "Novo Nordisk Pharmaceutical Industries, LP",
"finished": true,
"packaging": [
{
"sample": false,
"description": "5 SYRINGE in 1 CARTON (0169-2201-25) / 3 mL in 1 SYRINGE",
"package_ndc": "0169-2201-25",
"identifierStatus": "well-formed",
"marketing_start_date": "20210701"
}
],
"productId": "0169-2201_f999a4d9-129e-4cb2-88cb-2a855468882f",
"useDomain": "unknown",
"dosageForm": "INJECTION, SUSPENSION",
"productNdc": "0169-2201",
"deaSchedule": null,
"genericName": "insulin aspart",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "INSULIN ASPART",
"strength": "100 [iU]/mL"
}
],
"applicationNumber": "BLA021172",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20020911",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"M0011417",
"N0000175453"
],
"upc": [
"0301692200113"
],
"unii": [
"D933668QVX"
],
"rxcui": [
"351297",
"847191",
"977840",
"977842"
],
"spl_set_id": [
"1861fcee-7673-4afe-a206-08fa05c0add2"
],
"pharm_class_cs": [
"Insulin [CS]"
],
"pharm_class_epc": [
"Insulin Analog [EPC]"
],
"manufacturer_name": [
"Novo Nordisk Pharmaceutical Industries, LP"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0169-2201_f999a4d9-129e-4cb2-88cb-2a855468882f"